A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis
2007

A New Vaccine for Mycobacterium avium Subspecies paratuberculosis

Sample size: 22 publication 10 minutes Evidence: high

Author Information

Author(s): Gilbert Sarah C., Sridhar Saranya, Linedale Richard, Dierkes Nicola, Sidi-Boumedine Karim, Hermon-Taylor John

Primary Institution: St George's University of London

Hypothesis

Can a novel multi-antigen vaccine effectively immunize against Mycobacterium avium subspecies paratuberculosis?

Conclusion

The new vaccine was highly immunogenic and effectively reduced existing infections in mice without causing adverse effects.

Supporting Evidence

  • The vaccine showed significant immune responses in vaccinated mice.
  • Vaccination significantly reduced the load of Mycobacterium avium subspecies paratuberculosis in spleen and liver.
  • No adverse effects were observed in any of the vaccinated mice.

Takeaway

Scientists created a new vaccine to help protect against a germ that can make animals and people sick, and it worked well in mice without making them sick.

Methodology

The vaccine was tested on C57BL/6 mice using DNA-prime/MVA-boost and Ad5-prime/MVA-boost protocols.

Limitations

The study was conducted in mice, and further research is needed in naturally infected animals and humans.

Participant Demographics

C57BL/6 mice, 4-6 weeks old, female.

Statistical Information

P-Value

p=0.0002

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001229

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication